Dr. Sher, it sounds as though you've had some success in providing a universal publicly funded system through bulk purchasing for particular products important to Canadians—plasma products. Is there any reason, in your view, that the success you've experienced could not be replicated on a national basis for a broader range of medicines?
In other words, you've done it successfully: universal, free provision of these products to Canadians in bulk buying for plasma. Is there any reason we couldn't broaden that to more products?